Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
about
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liverGlobal gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancerPrognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysisClinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCCGlypican-3 expression and its relationship with recurrence of HCC after liver transplantation.The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.Cervical lymph node metastases from remote primary tumor sitesGlypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2.Metastases to nasal cavity and paranasal sinuses.Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian PatientsTargeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy.Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.Two functional domains in C. elegans glypican LON-2 can independently inhibit BMP-like signaling.Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.Diagnostic Value of Glypican-3 for Hepatocellular CarcinomasIn vivo fluorescence imaging of hepatocellular carcinoma using a novel GPC3-specific aptamer probe.Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
P2860
Q28587974-85D5FFD3-5313-4C0F-93E4-28EA9CE6866AQ28829385-776D4F49-26C0-4DC3-A675-AD85D2DE21AAQ33661257-AAC7A721-DE58-43B6-B3EC-5B871C5DDEB6Q35507495-8A7308A7-06AA-4407-978F-EF87B752AC02Q35963772-B3622245-E484-42BA-AADD-549AC3C35C0EQ36197579-30A9F711-5DA4-481D-A5DE-6D44C6EC376DQ36217858-C62A0370-91B4-47A0-B75A-F01A862EAC8DQ37122823-9409B362-B61A-4942-A931-839EA4060EEBQ37190697-0A3771C1-0E99-4B90-9370-B42F965F5017Q37645001-9F90F865-2FE6-4C80-BC5A-299D31744F23Q37685728-2EE5CEA7-BB02-45CF-B0B6-C6BBFE0A6D46Q38842833-44468C98-D256-4E9C-98F2-9DB53AB23930Q39122342-2EEE26EE-039E-489A-AF04-EEB8AA336B91Q39592084-3DADFB28-4E88-4FA1-8628-EA2CA33B81CAQ40316507-72E0AF6F-7C89-4821-BFAB-C1D55A9F6F02Q41138780-1FBC37F7-A603-4208-B460-481ACF65DC1BQ41529909-2AE85A1D-4175-41B3-91FB-74B7F211D812Q42114895-6714B067-74ED-49B4-AA59-8EA1C6CCEA38Q42176137-DF92F6A4-0D22-460C-950F-F2BB0E79B9F4Q45863309-3285E993-701B-42F4-81C9-E1207277FB45Q46252093-A613D757-49AC-48E0-A0F5-748641E88C9DQ47102060-E62A98E8-3E97-45FD-9C6F-DCE9DC58E78EQ53647594-1691B4A2-BB70-4743-96DF-72971ED929DAQ55189641-6D9E276B-108C-407A-A104-7B28F02BBEE1Q55436346-660ED4FE-3A35-418D-9331-17FF83AC2C60Q55478019-9FFD7403-717F-4C46-A3E2-09A36E5EABD4
P2860
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@en
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@nl
type
label
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@en
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@nl
prefLabel
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@en
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@nl
P1476
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
@en
P2093
Dina H Kandil
Kumarasen Cooper
P304
P356
10.1097/PAP.0B013E3181992455
P577
2009-03-01T00:00:00Z